Industry Liaison Forum
The Industry Liaison Forum (ILF) is an initiative of the International AIDS Society (IAS) with a mission to accelerate scientifically promising, ethical HIV research in resource-limited countries, with a particular focus on the role and responsibilities of industry as sponsors and supporters of research.
IAS-ILF and 15 other leading public and private sector organizations released a comprehensive research agenda designed to significantly advance global responses to HIV in women, girls and children.
The new consensus statement, Asking the Right Questions: Advancing an HIV Research Agenda for Women and Children, includes 20 specific recommendations to expand and improve responses to the HIV-related challenges facing women and children worldwide.
Read the related press release
- ILF-UNICEF satellite @ IAS 2013: Beyond Option B+
Sunday 30 June, 14h45-16h45 (Kuala Lumpur Convention Center)
- ILF-AVAC satellite @ IAS 2013: Expanding HIV Prevention Options for Women
Sunday 30 June, 17h00-19h00 (Kuala Lumpur Convention Center)
ILF event at CROI 2013
The meeting agenda and presentations from the ILF affiliated event held at CROI 2013 are now available. Please click here for access.
New ILF Strategic Plan 2012-2014
The new strategic plan outlining ILF’s priorities for the next three years was adopted at IAS 2011, and is available for viewing and download.
Gender in Editorial Policy
In line with the ILF's Consensus Statement recommendation that research data should be disaggregated by sex, we would like to congratulate The Lancet for adopting the Editorial Gender Policy. Notably, the Journal of the International AIDS Society (JIAS) introduced this policy earlier this year. Read more about the policy here: http://jiasociety.org/content/14/1/11.
The Red Card
The Red Card is an advocacy tool to be used at scientific conferences in order to raise awareness about sex and gender considerations in research, including methodological design, data collection and analysis of results. It is aimed at encouraging conference delegates and participants to raise the card and inquire about potential sex and gender differences and/or similarities, when these are not reported. After all, absence of evidence is not evidence of absence. If you are interested in using the Red Card to promote sex and gender considerations in research, please contact us ().
19 February 2013
Meeting event: Sex and Gender Differences in ARV-Based Prevention Research
(3 March 2013 in Atlanta, Georgia, USA)
14 December 2012
Eliminating new HIV infections among children and keeping their mothers alive is not just about pills
20 November 2012
UNAIDS reports a more than 50% drop in new HIV infections across 25 countries as countries approach the 1000 day deadline to achieve global AIDS targets
27 August 2012
U.S. FDA Approves Gilead's Stribild™, a Complete Once-Daily Single Tablet Regimen for Treatment-Naïve Adults with HIV-1 Infection
18 July 2012
ViiV Healthcare to Grant £1.5 million to the International AIDS Society (IAS) as part of a Global Initiative to promote and advance HIV research related to children affected by HIV
16 July 2012
FDA Approves First Drug To Prevent HIV Infection
20 February 2012
WHO upholds guidance on hormonal contraceptive use and HIV
Articles from previous years are available here
||2013 Sponsoring Industry Partners
A list of previous sponsoring industry partners is available here